Global X Cybersecurity vs Summit Therapeutics Inc — how do they compare? Global X Cybersecurity trades at $42.48, while Summit Therapeutics Inc trades at $15.9 (market cap $12.01B). The key difference: Global X Cybersecurity is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| BUG | SMMT | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $41.99 | $29.32 |
52-Week Low | $23.30 | $13.05 |
Market Cap | — | $12.01B |
Enterprise Value | — | $11.43B |
Trailing returns across standard periods
Latest headlines on both assets
BUG is a thematic ETF that invests in companies at the forefront of the global cybersecurity industry. It provides concentrated exposure to leaders in network security, endpoint protection, and cloud security, such as Fortinet, Akamai, and CrowdStrike.
Read more on BUG →Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →